American Resources (AREC)
(Delayed Data from NSDQ)
$0.65 USD
+0.02 (3.92%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $0.65 0.00 (0.46%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AREC 0.65 +0.02(3.92%)
Will AREC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AREC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AREC
American Resources Corporation (AREC) Reports Q1 Loss, Misses Revenue Estimates
Analysts Estimate Silvercorp (SVM) to Report a Decline in Earnings: What to Look Out for
AREC: What are Zacks experts saying now?
Zacks Private Portfolio Services
HudBay Minerals (HBM) Surpasses Q1 Earnings and Revenue Estimates
Earnings Preview: American Resources Corporation (AREC) Q1 Earnings Expected to Decline
Piedmont Lithium Inc. (PLL) Reports Q1 Loss, Lags Revenue Estimates
Other News for AREC
Arecor Therapeutics Raises £6.26 Million in Share Placement
Arecor Therapeutics Launches £1 Million Retail Offer
Arecor Therapeutics Launches £7 Million Fundraise
Arecor Therapeutics Announces AGM Results and Broker Change
UK shareholder meetings calendar - next 7 days